What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.
-
Narrated by:
-
By:
About this listen
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration’s (FDA) oversight of lab-developed tests (LDT). They covered:
- Details about the ruling to vacate the FDA’s rule on LDT oversight.
- What LDT oversight might look like in the future.
- How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet